Literature DB >> 22814226

Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.

Anita Umerska1, Krzysztof J Paluch, Iwona Inkielewicz-Stępniak, Maria Jose Santos-Martinez, Owen I Corrigan, Carlos Medina, Lidia Tajber.   

Abstract

The aim of this work was to study the formulation of pharmaceutically relevant polyelectrolyte complex nanoparticles (NPs) composed of hyaluronic acid (HA) and chitosan (CS) containing no crosslinkers. The influence of polymer mixing ratio, concentration and molecular weight as well as the type of counterion in chitosan salt on properties of the resulting NPs was examined. Formulations and their components were studied by laser light scattering, viscosity, infrared spectroscopy and microscopy. Physical stability, isoelectric points and cytotoxicity of selected NPs were determined. By appropriate modification of HA molecular weight, stable and non-sedimenting NPs were successfully formed. Sonication was found to be an effective method to reduce the molecular weight of HA from 2882±25 to 176±4 kDa with no chemical changes in the HA structure observed. High molecular weight CS formed micron-sized entities at all compositions investigated. Positively and negatively charged NPs were obtained depending on the mixing ratio of the polymers, with CS glutamate NPs yielding more negatively charged particles compared to CS chloride NPs. The smallest NPs (149±11 nm) were formed using HA with molecular weight of 176 kDa. Cytotoxicity of NPs was dependent on environmental pH but HA was found to exert cytoprotective effects on Caco-2 cells.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814226     DOI: 10.1016/j.ijpharm.2012.07.011

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.

Authors:  Svenja Sladek; Clodagh Kearney; Daniel Crean; Pieter A J Brama; Lidia Tajber; Karolina Fawcett; Margot C Labberte; Bernadette Leggett; David J Brayden
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  Stability of chitosan-a challenge for pharmaceutical and biomedical applications.

Authors:  Emilia Szymańska; Katarzyna Winnicka
Journal:  Mar Drugs       Date:  2015-04-01       Impact factor: 5.118

3.  Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia.

Authors:  Valeria Pereira de Sousa; Joanne Crean; Vinícius Raphael de Almeida Borges; Carlos Rangel Rodrigues; Lidia Tajber; Fabio Boylan; Lucio Mendes Cabral
Journal:  Int J Nanomedicine       Date:  2013-08-15

4.  On the Formation and Stability of Chitosan/Hyaluronan-Based Complex Coacervates.

Authors:  Franco Furlani; Pietro Parisse; Pasquale Sacco
Journal:  Molecules       Date:  2020-02-27       Impact factor: 4.411

5.  Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin.

Authors:  Anita Umerska; Caroline Gaucher; Felipe Oyarzun-Ampuero; Isabelle Fries-Raeth; Florence Colin; María Gabriela Villamizar-Sarmiento; Philippe Maincent; Anne Sapin-Minet
Journal:  Antioxidants (Basel)       Date:  2018-03-24

6.  The Role of Mucin in the Toxicological Impact of Polystyrene Nanoparticles.

Authors:  Iwona Inkielewicz-Stepniak; Lidia Tajber; Gavin Behan; Hongzhou Zhang; Marek W Radomski; Carlos Medina; Maria J Santos-Martinez
Journal:  Materials (Basel)       Date:  2018-05-03       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.